Evidence map›Paper›PMID 42207963›Full record

ArticleCancer research2026

ICAM1high Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration.

Ling Wu, Zhan Xu, Jun Wang, Fengshuo Liu, Yunfeng Ding, Yang Gao, Siyue Wang, Jun Liu, Hilda L Chan, Weiguo Wu and 20 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Ling WuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-5786-4315
Zhan XuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-2139-0576
Jun WangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.ORCID 0009-0003-8277-3006
Fengshuo LiuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-4651-7710
Yunfeng DingLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-6592-1159
Yang GaoDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, Ohio.ORCID 0000-0003-1832-4380
Siyue WangLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0009-0000-2892-4887
Jun LiuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-7419-283X
Hilda L ChanLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-6882-4274
Weiguo WuAdvanced Technology Cores, Baylor College of Medicine, Houston, Texas.ORCID 0009-0005-7981-350X
Yi-Hsuan WuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-7568-3948
Liqun YuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-1099-5860
Xiaoxin HaoLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-8763-3529
Xuan LiLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-0609-8822
David G EdwardsLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-8002-0607
Cher ShaLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-8813-9335
Tobie D LeeLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-5331-2997
Nan GuanLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0009-0005-2300-1131
Sergio AguirreLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-4352-7764
Luis Becerra-DominguezLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-7007-9402
Dane HoffmanLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-3934-4770
Xiang ChenLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-7628-516X
Charlotte Helena RivasLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-1408-7368
Xiaoyuan G YanThe Awty International School, Houston, Texas.ORCID 0009-0009-1806-2828
Igor L BadoIcahn School of Medicine at Mount Sinai , New York, New York.ORCID 0000-0001-8855-4750
Weijie ZhangLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-6462-6067
Qian ZhuLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-7062-8221
Arun SreekumarLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0001-8956-3675
Robert L SatcherDepartment of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-3356-4331
Xiang H-F ZhangLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-5674-8670

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Suzanne AW Fuqua · 2007 to 2026
$73.9M
Translational Research in Breast Cancer (SPORE)P50CA186784 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MATTHEW J ELLIS · 2014 to 2026
$24.5M
VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
Osteoclast-Independent Mechanisms of Early-Stage Bone Colonization of Breast CancerR01CA183878 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ZHANG, XIANG · 2014 to 2024
$3.5M
Next Generation Rat Models of ER+ Breast CancerR01CA271498 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Yi Li, Xiang Zhang · 2022 to 2026
$3.1M
Unveiling the mechanisms underlying secondary metastasis and possible therapeutic windowsR01CA251950 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ZHANG, XIANG · 2020 to 2024
$2.6M
Modulation of Epigenetic Target in the Bone to Treat Breast Cancer MetastasisR01CA277838 · NCI · RICE UNIVERSITY · PI Han Xiao, Xiang Zhang · 2023 to 2026
$2.6M
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone MetastasesR01CA221946 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ROWLEY, DAVID R · 2018 to 2022
$2.4M
Rewired Metabolism Regulates Vessel Normalization and ImmunosuppressionR01CA227904 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SREEKUMAR, ARUN, ZHANG, XIANG · 2019 to 2023
$2.3M
High Throughput Genomic Sequencer at BCM Core FacilityS10OD023469 · OD · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2017 to 2017
$600k
High Memory High-Performance Computer Cluster for Biomedical ResearchS10OD032185 · OD · BAYLOR COLLEGE OF MEDICINE · PI HILSENBECK, SUSAN G. · 2022 to 2022
$596k
Harnessing neutrophils to improve the efficacy of immune checkpoint inhibitors in breast cancerR00CA279899 · NCI · OHIO STATE UNIVERSITY · PI Yang Gao · 2025 to 2026
$497k
Cancer Prevention and Research Institute of Texas (CPRIT) RP180672Cancer Prevention and Research Institute of Texas (CPRIT) RP200504National Cancer Institute (NCI) CA183878National Cancer Institute (NCI) CA221946National Cancer Institute (NCI) CA227904National Cancer Institute (NCI) CA251950National Cancer Institute (NCI) CA253533National Cancer Institute (NCI) P50CA186784National Institutes of Health (NIH) CA125123National Institutes of Health (NIH) P30EY002520National Institutes of Health (NIH) S10OD023469National Institutes of Health (NIH) S10OD025240National Institutes of Health (NIH) S10OD032185NCI NIH HHS K99 CA279899NCI NIH HHS P30 CA125123NCI NIH HHS P50 CA186784NCI NIH HHS R00 CA279899NCI NIH HHS R01 CA183878NCI NIH HHS R01 CA221946NCI NIH HHS R01 CA227904NCI NIH HHS R01 CA251950NCI NIH HHS R01 CA271498NCI NIH HHS R01 CA277838NCRR NIH HHS S10 RR024574NEI NIH HHS P30 EY002520NIH HHS S10 OD023469NIH HHS S10 OD025240NIH HHS S10 OD032185U.S. Department of Defense (DOD) HT9425-23-1-0493
6 · The paper itself

Abstract

Neutrophils are a prominent component of the tumor microenvironment (TME) that can have both pro- and antitumor functions. By analyzing neutrophils across different human cancers, we revealed an ICAM1high subset enriched in the TME, which was also observed in murine triple-negative breast cancer (TNBC) models. ICAM1high neutrophils exhibited an enhanced capacity for cell-cell adhesion specifically with tumor cells retaining epithelial features, and this adhesion conferred mutual advantages to both cell types. In contrast, cancer cells with mesenchymal-like phenotypes were vulnerable to neutrophil-mediated cytotoxicity due to decreased cell adhesion and elastase resistance. These opposite effects drove tumor evolution toward a dichotomy of neutrophil-enriched, epithelial-like ecosystems and macrophage-enriched, mesenchymal-like ecosystems. As ICAM1high neutrophils can reverse migrate from tissue into the circulation, the adhesive and reverse migratory properties together mediate metastatic intravasation. Spatial transcriptomic and tissue microarray analyses demonstrated interactions between tumor cells, neutrophils, and endothelial cells in human TNBC, particularly in non-Hispanic Europeans compared with African American patients. Together, this study demonstrated tumor-immune coevolution in which neutrophils instruct the phenotypes and metastatic behaviors of TNBC, which may preferentially occur in patients of certain ancestries. SIGNIFICANCE: A distinct subset of ICAMhigh tumor-infiltrating neutrophils with increased adhesion and reverse transendothelial migration shapes tumor phenotypes and metastatic potential through mutually beneficial interactions with epithelial cancer cells.

Indexed as

Intercellular Adhesion Molecule-1NeutrophilsTriple Negative Breast NeoplasmsAnimalsCell AdhesionCell Line, TumorCell MovementFemaleHumansMiceNeoplasm MetastasisTumor MicroenvironmentICAM1 protein, humanIntercellular Adhesion Molecule-1

Identifiers

PMID42207963
PMCPMC13293467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.